| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin G | 27 | 2022 | 481 | 3.700 |
Why?
|
| Immunoglobulin M | 18 | 2019 | 172 | 3.420 |
Why?
|
| Antibodies, Bacterial | 16 | 2019 | 90 | 3.290 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 24 | 2015 | 507 | 3.000 |
Why?
|
| Antibodies, Viral | 11 | 2022 | 110 | 2.190 |
Why?
|
| Syphilis | 4 | 2019 | 15 | 2.030 |
Why?
|
| Antigens, Bacterial | 7 | 2016 | 54 | 1.710 |
Why?
|
| Tuberculosis | 5 | 2015 | 77 | 1.670 |
Why?
|
| Serologic Tests | 11 | 2015 | 46 | 1.530 |
Why?
|
| Sensitivity and Specificity | 33 | 2019 | 1753 | 1.340 |
Why?
|
| Reagent Kits, Diagnostic | 10 | 2014 | 54 | 1.270 |
Why?
|
| Antibodies, Antinuclear | 5 | 2017 | 171 | 1.220 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2012 | 103 | 1.150 |
Why?
|
| Bacterial Outer Membrane Proteins | 6 | 2007 | 21 | 1.120 |
Why?
|
| Bartonella henselae | 6 | 2011 | 9 | 1.100 |
Why?
|
| Treponema pallidum | 3 | 2019 | 5 | 1.100 |
Why?
|
| West Nile virus | 4 | 2008 | 8 | 1.060 |
Why?
|
| Bacterial Proteins | 7 | 2006 | 244 | 0.990 |
Why?
|
| Syphilis Serodiagnosis | 2 | 2019 | 6 | 0.820 |
Why?
|
| Immunoblotting | 3 | 2014 | 254 | 0.810 |
Why?
|
| Fluorescent Antibody Technique | 7 | 2011 | 282 | 0.790 |
Why?
|
| Vibrio | 5 | 2001 | 14 | 0.790 |
Why?
|
| Respiratory Tract Infections | 4 | 2013 | 91 | 0.760 |
Why?
|
| Immunoenzyme Techniques | 12 | 2016 | 196 | 0.750 |
Why?
|
| Immunoglobulin A | 6 | 2017 | 79 | 0.700 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2017 | 29 | 0.680 |
Why?
|
| Genes, Bacterial | 6 | 2001 | 40 | 0.640 |
Why?
|
| Immunoassay | 10 | 2010 | 64 | 0.620 |
Why?
|
| Cat-Scratch Disease | 5 | 2011 | 10 | 0.610 |
Why?
|
| Bacteriological Techniques | 3 | 2014 | 49 | 0.610 |
Why?
|
| Humans | 73 | 2022 | 68549 | 0.600 |
Why?
|
| Neutralization Tests | 2 | 2013 | 19 | 0.550 |
Why?
|
| West Nile Fever | 2 | 2008 | 7 | 0.550 |
Why?
|
| Hepatitis C | 1 | 2017 | 114 | 0.530 |
Why?
|
| Antibodies | 3 | 2014 | 241 | 0.530 |
Why?
|
| Tuberculin | 2 | 2006 | 2 | 0.530 |
Why?
|
| Blotting, Western | 11 | 2011 | 954 | 0.520 |
Why?
|
| False Positive Reactions | 8 | 2019 | 95 | 0.520 |
Why?
|
| Phosphatidylcholines | 2 | 2014 | 38 | 0.490 |
Why?
|
| Helicobacter Infections | 2 | 2009 | 40 | 0.480 |
Why?
|
| Interferon-gamma | 2 | 2006 | 241 | 0.480 |
Why?
|
| Chlamydophila Infections | 2 | 2011 | 6 | 0.480 |
Why?
|
| Helicobacter pylori | 2 | 2009 | 54 | 0.470 |
Why?
|
| Cardiolipins | 1 | 2014 | 12 | 0.470 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 9 | 2008 | 95 | 0.470 |
Why?
|
| Dengue | 1 | 2013 | 5 | 0.470 |
Why?
|
| Viruses | 1 | 2013 | 14 | 0.450 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2013 | 11 | 0.450 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2001 | 49 | 0.440 |
Why?
|
| Antibodies, Heterophile | 3 | 2004 | 11 | 0.430 |
Why?
|
| Antibodies, Protozoan | 4 | 2008 | 15 | 0.420 |
Why?
|
| Cholesterol | 1 | 2014 | 331 | 0.420 |
Why?
|
| Molecular Sequence Data | 14 | 2007 | 1446 | 0.400 |
Why?
|
| Mycoplasma pneumoniae | 3 | 2010 | 3 | 0.400 |
Why?
|
| Antigens, Viral | 5 | 2008 | 35 | 0.390 |
Why?
|
| Autoantibodies | 6 | 2017 | 434 | 0.390 |
Why?
|
| Bordetella pertussis | 1 | 2011 | 4 | 0.390 |
Why?
|
| Chlamydia | 1 | 2011 | 5 | 0.380 |
Why?
|
| Child, Preschool | 11 | 2013 | 3187 | 0.380 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2011 | 60 | 0.370 |
Why?
|
| Algorithms | 1 | 2016 | 1195 | 0.370 |
Why?
|
| Chlamydia Infections | 1 | 2011 | 41 | 0.370 |
Why?
|
| DNA, Bacterial | 9 | 2010 | 150 | 0.370 |
Why?
|
| Adult | 24 | 2017 | 21379 | 0.370 |
Why?
|
| Adolescent | 14 | 2017 | 8904 | 0.360 |
Why?
|
| Herpes Simplex | 2 | 2008 | 35 | 0.360 |
Why?
|
| Brucellosis | 1 | 2010 | 2 | 0.360 |
Why?
|
| Brucella | 1 | 2010 | 3 | 0.360 |
Why?
|
| Agglutination Tests | 1 | 2010 | 9 | 0.360 |
Why?
|
| Rabies virus | 1 | 2009 | 1 | 0.340 |
Why?
|
| Male | 28 | 2017 | 37283 | 0.340 |
Why?
|
| Rabies | 1 | 2009 | 5 | 0.340 |
Why?
|
| Complement Fixation Tests | 2 | 2006 | 3 | 0.340 |
Why?
|
| Amino Acid Sequence | 11 | 2007 | 1082 | 0.340 |
Why?
|
| Pneumonia, Mycoplasma | 2 | 2010 | 2 | 0.340 |
Why?
|
| Smoking | 1 | 2017 | 1449 | 0.330 |
Why?
|
| Feces | 1 | 2009 | 88 | 0.330 |
Why?
|
| Simplexvirus | 1 | 2008 | 26 | 0.330 |
Why?
|
| Middle Aged | 18 | 2017 | 21119 | 0.330 |
Why?
|
| HIV-1 | 2 | 2001 | 177 | 0.320 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2008 | 9 | 0.320 |
Why?
|
| Female | 25 | 2017 | 38021 | 0.320 |
Why?
|
| Infant | 7 | 2013 | 2891 | 0.320 |
Why?
|
| Antigens, Protozoan | 1 | 2008 | 10 | 0.320 |
Why?
|
| Child | 14 | 2013 | 6401 | 0.320 |
Why?
|
| Protozoan Proteins | 1 | 2008 | 25 | 0.320 |
Why?
|
| Siderophores | 2 | 2000 | 16 | 0.320 |
Why?
|
| Aged | 15 | 2017 | 14842 | 0.310 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2008 | 47 | 0.310 |
Why?
|
| Cloning, Molecular | 7 | 2007 | 357 | 0.300 |
Why?
|
| Infant, Newborn | 7 | 2013 | 2455 | 0.300 |
Why?
|
| Prevalence | 3 | 2017 | 1609 | 0.290 |
Why?
|
| Base Sequence | 11 | 2007 | 1015 | 0.290 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2007 | 21 | 0.290 |
Why?
|
| Membrane Transport Proteins | 1 | 2007 | 81 | 0.290 |
Why?
|
| Malaria | 1 | 2007 | 26 | 0.290 |
Why?
|
| Carrier Proteins | 2 | 2001 | 597 | 0.290 |
Why?
|
| Chagas Disease | 1 | 2006 | 8 | 0.270 |
Why?
|
| Yersinia | 1 | 2005 | 2 | 0.270 |
Why?
|
| Yersinia Infections | 1 | 2005 | 2 | 0.270 |
Why?
|
| Borrelia burgdorferi | 1 | 2005 | 11 | 0.270 |
Why?
|
| Hemolysin Proteins | 1 | 2005 | 9 | 0.260 |
Why?
|
| Hymenoptera | 2 | 1996 | 4 | 0.260 |
Why?
|
| Reproducibility of Results | 7 | 2009 | 2077 | 0.250 |
Why?
|
| Acyltransferases | 1 | 2004 | 40 | 0.250 |
Why?
|
| Young Adult | 5 | 2017 | 5710 | 0.250 |
Why?
|
| Immunoelectrophoresis | 2 | 2006 | 16 | 0.240 |
Why?
|
| Insect Bites and Stings | 2 | 1996 | 47 | 0.240 |
Why?
|
| Cross Reactions | 4 | 2007 | 57 | 0.240 |
Why?
|
| False Negative Reactions | 3 | 2016 | 63 | 0.240 |
Why?
|
| Aged, 80 and over | 6 | 2013 | 4843 | 0.230 |
Why?
|
| Protozoan Infections | 1 | 2003 | 3 | 0.230 |
Why?
|
| Disease Vectors | 1 | 2003 | 8 | 0.230 |
Why?
|
| Antiphospholipid Syndrome | 2 | 2017 | 25 | 0.230 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 397 | 0.230 |
Why?
|
| Legionella pneumophila | 1 | 2003 | 6 | 0.230 |
Why?
|
| Virus Diseases | 1 | 2003 | 31 | 0.230 |
Why?
|
| Plasmids | 2 | 1997 | 258 | 0.220 |
Why?
|
| Repressor Proteins | 3 | 1994 | 182 | 0.220 |
Why?
|
| Bites and Stings | 1 | 2003 | 34 | 0.220 |
Why?
|
| Goats | 2 | 2001 | 17 | 0.220 |
Why?
|
| Mycoses | 1 | 2003 | 60 | 0.220 |
Why?
|
| Predictive Value of Tests | 5 | 2008 | 1465 | 0.220 |
Why?
|
| Bacterial Infections | 1 | 2003 | 163 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 6 | 2010 | 492 | 0.200 |
Why?
|
| Confidence Intervals | 2 | 2014 | 242 | 0.200 |
Why?
|
| Autoimmune Diseases | 2 | 2017 | 186 | 0.200 |
Why?
|
| HIV Antibodies | 1 | 2001 | 28 | 0.190 |
Why?
|
| Herpesvirus 4, Human | 4 | 2008 | 30 | 0.190 |
Why?
|
| Microspheres | 5 | 2004 | 59 | 0.190 |
Why?
|
| HIV Seropositivity | 1 | 2001 | 65 | 0.190 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 597 | 0.190 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1999 | 32 | 0.180 |
Why?
|
| Oxazoles | 1 | 2000 | 17 | 0.180 |
Why?
|
| Molecular Weight | 4 | 2007 | 358 | 0.180 |
Why?
|
| Reference Standards | 3 | 2009 | 115 | 0.180 |
Why?
|
| Paraproteinemias | 1 | 1999 | 4 | 0.180 |
Why?
|
| Electrophoresis, Capillary | 1 | 1999 | 15 | 0.170 |
Why?
|
| Reagins | 1 | 2019 | 1 | 0.170 |
Why?
|
| Amides | 1 | 2000 | 86 | 0.170 |
Why?
|
| Automation, Laboratory | 1 | 2019 | 5 | 0.170 |
Why?
|
| Serum Albumin | 1 | 1999 | 104 | 0.170 |
Why?
|
| Animals | 17 | 2011 | 20880 | 0.160 |
Why?
|
| Heme | 1 | 1998 | 17 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 700 | 0.160 |
Why?
|
| Antibody Specificity | 5 | 2007 | 98 | 0.160 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2007 | 230 | 0.150 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2008 | 24 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2001 | 753 | 0.150 |
Why?
|
| Shigella sonnei | 1 | 1997 | 3 | 0.150 |
Why?
|
| Periodontitis | 1 | 2017 | 47 | 0.140 |
Why?
|
| RNA, Viral | 1 | 2017 | 93 | 0.140 |
Why?
|
| Area Under Curve | 2 | 2015 | 238 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 1997 | 107 | 0.140 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 1996 | 15 | 0.140 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2007 | 42 | 0.140 |
Why?
|
| Cats | 3 | 2011 | 292 | 0.140 |
Why?
|
| Hepacivirus | 1 | 2017 | 90 | 0.140 |
Why?
|
| Retrospective Studies | 5 | 2013 | 7268 | 0.140 |
Why?
|
| Transcription, Genetic | 4 | 2001 | 562 | 0.140 |
Why?
|
| Diptera | 1 | 1996 | 9 | 0.140 |
Why?
|
| Vibrio cholerae | 2 | 1994 | 6 | 0.140 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 2007 | 7 | 0.130 |
Why?
|
| Thrombosis | 1 | 2017 | 218 | 0.130 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 132 | 0.130 |
Why?
|
| Acute Disease | 2 | 2016 | 658 | 0.130 |
Why?
|
| Dysentery, Bacillary | 2 | 1997 | 8 | 0.130 |
Why?
|
| Anaphylaxis | 1 | 1996 | 43 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2007 | 110 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2007 | 272 | 0.130 |
Why?
|
| DNA | 1 | 1997 | 597 | 0.130 |
Why?
|
| Utah | 2 | 2012 | 27 | 0.120 |
Why?
|
| ROC Curve | 1 | 2015 | 392 | 0.120 |
Why?
|
| Treponema | 1 | 2014 | 1 | 0.120 |
Why?
|
| Toxoplasma | 2 | 2006 | 23 | 0.120 |
Why?
|
| Tertiary Healthcare | 1 | 2013 | 6 | 0.110 |
Why?
|
| Hypersensitivity | 1 | 1994 | 52 | 0.110 |
Why?
|
| Biomarkers | 2 | 2017 | 1593 | 0.110 |
Why?
|
| Cattle | 4 | 2001 | 475 | 0.110 |
Why?
|
| Restriction Mapping | 4 | 1996 | 85 | 0.110 |
Why?
|
| Toxoplasmosis, Congenital | 2 | 2006 | 4 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1549 | 0.110 |
Why?
|
| Georgia | 1 | 2013 | 161 | 0.110 |
Why?
|
| Seasons | 1 | 2013 | 129 | 0.110 |
Why?
|
| Escherichia coli | 3 | 2005 | 368 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 546 | 0.110 |
Why?
|
| Genes, Regulator | 1 | 1992 | 17 | 0.100 |
Why?
|
| RNA, Bacterial | 3 | 2001 | 30 | 0.100 |
Why?
|
| CDC2 Protein Kinase | 2 | 1992 | 13 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2016 | 1329 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 100 | 0.100 |
Why?
|
| Endocarditis, Bacterial | 1 | 2011 | 32 | 0.100 |
Why?
|
| Shigella | 1 | 1991 | 1 | 0.100 |
Why?
|
| Chlamydophila | 1 | 2011 | 1 | 0.100 |
Why?
|
| Adhesins, Bacterial | 1 | 2011 | 13 | 0.100 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2011 | 60 | 0.100 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1991 | 26 | 0.100 |
Why?
|
| Pertussis Toxin | 1 | 2011 | 72 | 0.100 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2011 | 21 | 0.090 |
Why?
|
| Blotting, Northern | 2 | 2001 | 189 | 0.090 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2010 | 13 | 0.090 |
Why?
|
| Iron | 4 | 2000 | 197 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1991 | 195 | 0.090 |
Why?
|
| Spleen | 1 | 1991 | 301 | 0.090 |
Why?
|
| Colitis | 1 | 2011 | 156 | 0.090 |
Why?
|
| Heart Valve Prosthesis | 1 | 2011 | 222 | 0.090 |
Why?
|
| Rabies Vaccines | 1 | 2009 | 4 | 0.090 |
Why?
|
| Blood | 2 | 2007 | 40 | 0.080 |
Why?
|
| Viral Envelope Proteins | 1 | 2009 | 43 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2009 | 219 | 0.080 |
Why?
|
| HIV-2 | 1 | 2008 | 4 | 0.080 |
Why?
|
| Cytokines | 2 | 2004 | 866 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2001 | 614 | 0.080 |
Why?
|
| Herpesvirus 1, Human | 1 | 2008 | 30 | 0.080 |
Why?
|
| Abortion, Habitual | 1 | 2008 | 13 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2007 | 208 | 0.080 |
Why?
|
| Phospholipids | 1 | 2008 | 108 | 0.080 |
Why?
|
| Angiomatosis, Bacillary | 1 | 2007 | 3 | 0.080 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2007 | 6 | 0.080 |
Why?
|
| Vaccination | 1 | 2009 | 182 | 0.080 |
Why?
|
| Virulence | 2 | 1998 | 51 | 0.070 |
Why?
|
| Rheumatoid Factor | 1 | 2007 | 21 | 0.070 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2007 | 7 | 0.070 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2007 | 22 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 322 | 0.070 |
Why?
|
| Antibodies, Fungal | 1 | 2006 | 9 | 0.070 |
Why?
|
| Seroepidemiologic Studies | 2 | 2022 | 41 | 0.070 |
Why?
|
| Ear, Inner | 1 | 2006 | 47 | 0.070 |
Why?
|
| Respirovirus | 1 | 2006 | 1 | 0.070 |
Why?
|
| Influenza B virus | 1 | 2006 | 2 | 0.070 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2006 | 9 | 0.070 |
Why?
|
| Skin Tests | 1 | 2006 | 30 | 0.070 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2006 | 10 | 0.070 |
Why?
|
| Influenza A virus | 1 | 2006 | 13 | 0.070 |
Why?
|
| Trypanosoma cruzi | 1 | 2006 | 7 | 0.070 |
Why?
|
| Linear Models | 1 | 2008 | 521 | 0.070 |
Why?
|
| Collodion | 1 | 2005 | 3 | 0.070 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2006 | 30 | 0.070 |
Why?
|
| Blotting, Southern | 2 | 1998 | 67 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 59 | 0.070 |
Why?
|
| Actins | 1 | 2007 | 249 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2006 | 79 | 0.060 |
Why?
|
| Gene Components | 1 | 2004 | 1 | 0.060 |
Why?
|
| Mycobacterium bovis | 1 | 2004 | 3 | 0.060 |
Why?
|
| BCG Vaccine | 1 | 2004 | 12 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2006 | 172 | 0.060 |
Why?
|
| Tuberculin Test | 1 | 2004 | 16 | 0.060 |
Why?
|
| Antigens, Nuclear | 1 | 2004 | 24 | 0.060 |
Why?
|
| Polyradiculoneuropathy | 1 | 2004 | 3 | 0.060 |
Why?
|
| Immunologic Techniques | 1 | 2003 | 30 | 0.060 |
Why?
|
| Birds | 1 | 2003 | 17 | 0.060 |
Why?
|
| Legionnaires' Disease | 1 | 2003 | 11 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 376 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 511 | 0.050 |
Why?
|
| Mice | 3 | 2001 | 8474 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 509 | 0.050 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2002 | 13 | 0.050 |
Why?
|
| Genetic Complementation Test | 2 | 1993 | 35 | 0.050 |
Why?
|
| DNA, Viral | 2 | 2007 | 114 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2002 | 48 | 0.050 |
Why?
|
| Dogs | 1 | 2003 | 490 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 1993 | 165 | 0.050 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2002 | 31 | 0.050 |
Why?
|
| Hemin | 1 | 2001 | 10 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2002 | 101 | 0.050 |
Why?
|
| Immunoglobulin E | 2 | 2002 | 91 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 579 | 0.050 |
Why?
|
| Serum Albumin, Bovine | 1 | 2001 | 43 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2001 | 20 | 0.050 |
Why?
|
| Celiac Disease | 1 | 2001 | 17 | 0.050 |
Why?
|
| Sheep | 1 | 2001 | 128 | 0.050 |
Why?
|
| HIV Infections | 1 | 2008 | 775 | 0.050 |
Why?
|
| Transglutaminases | 1 | 2001 | 67 | 0.050 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2000 | 9 | 0.050 |
Why?
|
| DNA Glycosylases | 1 | 2000 | 21 | 0.050 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2000 | 1 | 0.050 |
Why?
|
| Iron-Binding Proteins | 1 | 2000 | 5 | 0.050 |
Why?
|
| Autoanalysis | 1 | 1999 | 11 | 0.040 |
Why?
|
| Milk Proteins | 1 | 1999 | 22 | 0.040 |
Why?
|
| Incidence | 1 | 2003 | 1582 | 0.040 |
Why?
|
| Complement Hemolytic Activity Assay | 1 | 1999 | 4 | 0.040 |
Why?
|
| Complement Pathway, Classical | 1 | 1999 | 22 | 0.040 |
Why?
|
| Health Personnel | 1 | 2022 | 286 | 0.040 |
Why?
|
| Prognosis | 1 | 2003 | 2093 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 1993 | 1663 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 756 | 0.040 |
Why?
|
| Rubella | 1 | 1997 | 1 | 0.040 |
Why?
|
| Parvoviridae Infections | 1 | 1997 | 2 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1998 | 12 | 0.040 |
Why?
|
| Syphilis, Congenital | 1 | 1997 | 5 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1745 | 0.040 |
Why?
|
| Allergens | 1 | 1998 | 54 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1997 | 23 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1997 | 95 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 1999 | 652 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 1 | 1997 | 69 | 0.040 |
Why?
|
| Basement Membrane | 1 | 1996 | 48 | 0.040 |
Why?
|
| Animals, Suckling | 1 | 1996 | 7 | 0.040 |
Why?
|
| Vibrio Infections | 1 | 1996 | 3 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 1996 | 24 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 1999 | 295 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1996 | 25 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1997 | 226 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 1996 | 20 | 0.030 |
Why?
|
| Hydrolases | 1 | 1996 | 20 | 0.030 |
Why?
|
| Lyme Disease | 1 | 1996 | 17 | 0.030 |
Why?
|
| Fetal Blood | 3 | 2002 | 131 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 1999 | 318 | 0.030 |
Why?
|
| Transferrin | 1 | 1996 | 94 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 4655 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1992 | 79 | 0.030 |
Why?
|
| Herpesviridae Infections | 2 | 1997 | 23 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 1992 | 234 | 0.030 |
Why?
|
| Risk Factors | 1 | 2003 | 5720 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 1999 | 807 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1993 | 89 | 0.030 |
Why?
|
| Species Specificity | 1 | 1993 | 302 | 0.030 |
Why?
|
| Proline | 1 | 1992 | 52 | 0.030 |
Why?
|
| DNA Primers | 3 | 1997 | 302 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1992 | 122 | 0.030 |
Why?
|
| Mexico | 1 | 2011 | 38 | 0.020 |
Why?
|
| United States | 1 | 2004 | 7338 | 0.020 |
Why?
|
| Phosphorylation | 2 | 1992 | 1200 | 0.020 |
Why?
|
| Arizona | 1 | 1991 | 9 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1991 | 49 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1991 | 39 | 0.020 |
Why?
|
| Travel | 1 | 1991 | 38 | 0.020 |
Why?
|
| Phosphatidylglycerols | 1 | 2008 | 8 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2008 | 22 | 0.020 |
Why?
|
| Phosphatidic Acids | 1 | 2008 | 11 | 0.020 |
Why?
|
| Phosphatidylinositols | 1 | 2008 | 40 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 1 | 2008 | 20 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1999 | 219 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 334 | 0.020 |
Why?
|
| Haplorhini | 1 | 2007 | 44 | 0.020 |
Why?
|
| Serum | 1 | 2007 | 24 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2006 | 27 | 0.020 |
Why?
|
| Brain | 2 | 2000 | 2176 | 0.020 |
Why?
|
| Porins | 1 | 2006 | 3 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2007 | 117 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2006 | 58 | 0.020 |
Why?
|
| Autoantigens | 1 | 2006 | 91 | 0.020 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2006 | 6 | 0.020 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2006 | 7 | 0.020 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2006 | 5 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 144 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2006 | 92 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 742 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 1026 | 0.020 |
Why?
|
| Globosides | 1 | 2004 | 2 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 261 | 0.010 |
Why?
|
| Proteins | 1 | 2006 | 473 | 0.010 |
Why?
|
| Hypergammaglobulinemia | 1 | 2002 | 2 | 0.010 |
Why?
|
| Serotyping | 1 | 2002 | 16 | 0.010 |
Why?
|
| Fluorescence | 1 | 2002 | 104 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2006 | 617 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2002 | 165 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2002 | 124 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 2265 | 0.010 |
Why?
|
| Rats | 2 | 2001 | 5300 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2002 | 175 | 0.010 |
Why?
|
| Reticulin | 1 | 2001 | 3 | 0.010 |
Why?
|
| Gliadin | 1 | 2001 | 5 | 0.010 |
Why?
|
| Primates | 1 | 2001 | 14 | 0.010 |
Why?
|
| Stomach | 1 | 2001 | 80 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 2000 | 8 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2000 | 16 | 0.010 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2000 | 17 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2000 | 23 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 2000 | 30 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7028 | 0.010 |
Why?
|
| Esophagus | 1 | 2001 | 303 | 0.010 |
Why?
|
| Liposomes | 1 | 1999 | 107 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1999 | 135 | 0.010 |
Why?
|
| Infectious Mononucleosis | 1 | 1997 | 7 | 0.010 |
Why?
|
| Tumor Virus Infections | 1 | 1997 | 32 | 0.010 |
Why?
|
| Paraffin Embedding | 1 | 1997 | 47 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 2673 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 1997 | 58 | 0.010 |
Why?
|
| Borrelia burgdorferi Group | 1 | 1996 | 1 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1997 | 258 | 0.010 |
Why?
|
| Kidney | 1 | 2001 | 945 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1999 | 705 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1999 | 481 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1994 | 60 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 2083 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 420 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1992 | 237 | 0.010 |
Why?
|
| Peptides | 1 | 1992 | 455 | 0.010 |
Why?
|
| Mutation | 1 | 1994 | 1213 | 0.010 |
Why?
|
| Pyoderma | 1 | 1988 | 2 | 0.010 |
Why?
|
| Hepatitis | 1 | 1988 | 25 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1988 | 185 | 0.000 |
Why?
|